Alvotech/$ALVO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Ticker
$ALVO
Sector
Primary listing
Employees
1,279
Headquarters
Luxembourg, Luxembourg
Website
Alvotech Metrics
BasicAdvanced
$1.1bn
36.53
$0.10
0.25
-
Price and volume
Market cap
$1.1bn
Beta
0.25
52-week high
$11.85
52-week low
$3.03
Average daily volume
435k
Financial strength
Current ratio
1.888
Quick ratio
1.01
Long term debt to equity
-492.165
Total debt to equity
-509.389
Interest coverage (TTM)
0.53%
Profitability
EBITDA (TTM)
103.981
Gross margin (TTM)
60.37%
Net profit margin (TTM)
4.74%
Operating margin (TTM)
14.06%
Effective tax rate (TTM)
79.52%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
3.82%
Return on equity (TTM)
-8.01%
Valuation
Price to earnings (TTM)
36.529
Price to revenue (TTM)
1.732
Price to book
-3.86
Price to tangible book (TTM)
-2.9
Price to free cash flow (TTM)
-6.97
Free cash flow yield (TTM)
-14.35%
Free cash flow per share (TTM)
-0.505
Growth
Revenue change (TTM)
19.70%
Earnings per share change (TTM)
-111.56%
3-year revenue growth (CAGR)
90.62%
3-year earnings per share growth (CAGR)
-66.65%
Alvotech News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alvotech stock?
Alvotech (ALVO) has a market cap of $1.1B as of May 06, 2026.
What is the P/E ratio for Alvotech stock?
The price to earnings (P/E) ratio for Alvotech (ALVO) stock is 36.53 as of May 06, 2026.
Does Alvotech stock pay dividends?
No, Alvotech (ALVO) stock does not pay dividends to its shareholders as of May 06, 2026.
When is the next Alvotech dividend payment date?
Alvotech (ALVO) stock does not pay dividends to its shareholders.
What is the beta indicator for Alvotech?
Alvotech (ALVO) has a beta rating of 0.25. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.